TP53 and plasma cell myeloma: Genetic defects in 17p are complex and include either a deletion—more or less the length of the short arm of chromosome 17—alone or only a mutation in one allele of the TP53 gene or a biallelic inactivation of TP53, the so-called double-hit myeloma entity, described as displaying an extremely poor prognosis [25].